Look for any podcast host, guest or anyone
Showing episodes and shows of

FNLA

Shows

Medication TalkMedication TalkAntidepressant InsightsListen in as our expert panel discusses practical considerations for starting and optimizing antidepressants for treating depression and anxiety.  You’ll listen to panelists cover various aspects of antidepressant use, such as serotonin syndrome, QT prolongation, and weight gain concerns.Special guest(s):Tammie Lee Demler, BS, PharmD, MBA, BCGP, BCPP Director of Pharmacy and Residency Programs, New York State Office of Mental Health State University of New York at Buffalo School of Pharmacy and Pharmaceutical Sciences Sarah E. Grady, PharmD, BCPS, BCPPProfessor, Drake University College of Pharmacy and Health SciencesClinical Pharmacist, Inpatient Behavioral Health Unit, Broadl...2025-07-0138 minMedication TalkMedication TalkMeds for Alzheimer DementiaListen in as our expert panel discusses medications for the treatment of Alzheimer dementia.  They'll review the risks and benefits of cholinesterase inhibitors, memantine, and the anti-amyloid monoclonal antibodies.  And you’ll hear strategies for managing behavioral and psychological symptoms of dementia.   Special guests:Tatyana Gurvich, PharmD, BCGP, APhAssociate Professor of Clinical PharmacyMann USC School of PharmacyUCI Senior Health CenterCandace Pierce, DNP, RN, CNE, COINurse Educator, Nurse Planner, and Healthcare Leader, Colibri HealthcareDarlene Moyer, MD, FAAFPAssociate Director, HonorHealth Family Medicine Residency ProgramAssociate Professor of Clinical Practice – SOMME – Arizona State UniversityClinical Associate Professor – University of Arizona College of Medicine...2025-06-0135 minMedication TalkMedication TalkMedications for Opioid Use DisorderListen in as our expert panel discusses medications for management of opioid use disorder. They’ll review strategies to optimize buprenorphine use and clarify the role of methadone and naltrexone.Special guest:Tyler J. Varisco, PharmD, PhDUniversity of Houston College of Pharmacy Assistant Professor, Department of Pharmaceutical Health Outcomes and PolicyAssistant Director, The PREMIER CenterYou’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLM, Clinical Associate Professor of Family Medicine for the Prisma Health/USC School of Medicine Greenville Family Medicine Residency Program at the Uni...2025-05-0137 minMedication TalkMedication TalkBronchitis and Pneumonia TreatmentIn this episode, listen in as our expert panel digs into identifying and treating acute bronchitis and community-acquired pneumonia. They’ll discuss when antibiotics are appropriate, which antibiotics to use, and other management tips.You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLM, Program Director for the Prisma Health/USC School of Medicine Greenville Family Medicine Residency Program and Clinical Associate Professor at the University of South Carolina School of Medicine, GreenvilleAndrea Darby Stewart, MD, Associate Director, Honor Health Family Medicine Residency Program and Clinical Professor of Fam...2025-03-0134 minMedication TalkMedication TalkAsthma and COPD TreatmentSpecial guest Lori A. Wilken, PharmD, FCCP, BCACP, NCTTP, AE-C, Clinical Assistant Professor in the Department of Pharmacy Practice at the University of Illinois, Chicago, joins us to talkabout Asthma and COPD treatment.Listen in as we discuss answers to your big questions about treatment of asthma and COPD. You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLM, Clinical Assistant Professor of Family Medicine, Prisma Health/USC-SOMG Family Medicine Residency Program at the USC School of Medicine GreenvilleAndrea Darby Stewart, MD, Associate Direc...2024-10-0135 minMedication TalkMedication TalkPrecepting: Helping Learners SucceedIn this episode, listen in as our expert panelists discuss tips for creating successful learning experiences for students and residents.  We’ll review various teaching tools and summarize strategies for incorporating learners into your practice. We’ll also discuss different approaches for providing meaningful feedback and managing challenging situations with learners.Our panel for this conversation includes: Andrea Darby Stewart, MD; Associate Director, Honor Health Family Medicine Residency Program; Clinical Professor of Family, Community & Occupational Medicine, University of Arizona College of Medicine – PhoenixMary Franks, MSN, APRN-FPA, FNP-C; Nurse Planner, NetCE; Adjunct Professor, Bradley University; Nurse Practitioner, Carle He...2024-09-0147 minLipid InsightsLipid InsightsS5E1: A Focused Update to the 2019 NLA Scientific Statement On The Use of Lp(a) in Clinical PracticeAlan Brown, MD, FNLA talks with Christie Ballantyne, MD, FNLA about the publication of "A Focused Update to the 2019 NLA Scientific Statement On The Use of Lp(a) in Clinical Practice"2024-05-0331 minMedication TalkMedication TalkManaging Chronic Coronary DiseaseSpecial guest Dave L. Dixon, PharmD, FACC, FAHA, FCCP, FNLA, BCACP, CDCES, CLS, the Nancy L. and Ronald H. McFarlane Professor of Pharmacy and Chair of the Department of Pharmacotherapy & Outcomes Science at the Virginia Commonwealth University School of Pharmacy, joins us to talk about chronic coronary disease.Listen in as he discusses the management of chronic coronary disease with a focus on the new American College of Cardiology/American Heart Association guidelines.You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:Anthony A. Donato, Jr...2023-11-0133 minObesity: A DiseaseObesity: A DiseaseEpisode 87: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk with Dr. Bindlish, Part 2 of 3In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Bindlish was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care...2023-08-2818 minObesity: A DiseaseObesity: A DiseaseEpisode 87: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk with Dr. Bindlish, Part 2 of 3In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Bindlish was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care...2023-08-2818 minObesity: A DiseaseObesity: A DiseaseEpisode 85: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk with Dr. Bindlish, Part 1 of 3In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Bindlish was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care...2023-08-0717 minObesity: A DiseaseObesity: A DiseaseEpisode 85: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk with Dr. Bindlish, Part 1 of 3In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Bindlish was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care...2023-08-0717 minLipid InsightsLipid InsightsS4E2: Nutrition Interventions for Adults with DyslipidemiaAlan Brown, MD, FNLA talks with Carol F. Kirkpatrick, PhD, MPH, RDN, CLS, FNLA and Kevin C Maki, PhD, CLS, FNLA, FTOS, FACN to discuss Nutrition Interventions for Adults with Dyslipidemia. 2023-07-3136 minObesity: A DiseaseObesity: A DiseaseEpisode 83: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk, Part 3 of 3In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in Obesity Pillars, for which Dr. Lowe-Clayton was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health...2023-05-1816 minObesity: A DiseaseObesity: A DiseaseEpisode 83: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk, Part 3 of 3In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in Obesity Pillars, for which Dr. Lowe-Clayton was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health...2023-05-1816 minObesity: A DiseaseObesity: A DiseaseEpisode 81: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk, Part 2 of 3In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in Obesity Pillars, for which Dr. Lowe-Clayton was a co-author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care...2023-04-2615 minObesity: A DiseaseObesity: A DiseaseEpisode 81: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk, Part 2 of 3In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in Obesity Pillars, for which Dr. Lowe-Clayton was a co-author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care...2023-04-2615 minObesity: A DiseaseObesity: A DiseaseEpisode 78: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic RiskIn this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Lowe-Clayton was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care...2023-03-2421 minObesity: A DiseaseObesity: A DiseaseEpisode 78: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic RiskIn this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Lowe-Clayton was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care...2023-03-2421 minObesity: A DiseaseObesity: A DiseaseEpisode 73: Article Reviews: Clinical Practice Statements for the Management of Obesity – Nutrition and Physical Activity, Part 2 of 2: Body CompositionOMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Karli Burridge, PA-C, MMS, FOMA about the Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) for which she was first author, titled 'Nutrition and Physical Activity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program. Topics include personal history documentation; laboratory procedures; components of energy expenditure; non-exercise activity thermogenesis (NEAT); accurately assessing and understanding body composition; body fat cut-off levels and the inclusion of a "pre-obesity" category. In our article review podcasts, we have carefully...2022-12-1620 minObesity: A DiseaseObesity: A DiseaseEpisode 73: Article Reviews: Clinical Practice Statements for the Management of Obesity - Nutrition and Physical Activity, Part 2 of 2: Body CompositionOMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Karli Burridge, PA-C, MMS, FOMA about the Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) for which she was first author, titled 'Nutrition and Physical Activity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program. Topics include personal history documentation; laboratory procedures; components of energy expenditure; non-exercise activity thermogenesis (NEAT); accurately assessing and understanding body composition; body fat cut-off levels and the inclusion of a "pre-obesity" category. In our article review podcasts, we have carefully...2022-12-1620 minObesity: A DiseaseObesity: A DiseaseEpisode 72: Article Reviews: Clinical Practice Statements for the Management of Obesity – Nutrition and Physical Activity, Part 1 of 2: Effective Patient Documentation; Electronic Medical Records (EMR’s) and Energy ExpenditureOMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Karli Burridge, PA-C, MMS, FOMA about the Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) for which she was first author, titled 'Nutrition and Physical Activity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program. Topics include personal history documentation; laboratory procedures; components of energy expenditure; non-exercise activity thermogenesis (NEAT); accurately assessing and understanding body composition; body fat cut-off levels and the inclusion of a "pre-obesity" category. In our article review podcasts, we have carefully...2022-12-1525 minObesity: A DiseaseObesity: A DiseaseEpisode 72: Article Reviews: Clinical Practice Statements for the Management of Obesity - Nutrition and Physical Activity, Part 1 of 2: Effective Patient Documentation; Electronic Medical Records (EMR's) and Energy ExpenditureOMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Karli Burridge, PA-C, MMS, FOMA about the Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) for which she was first author, titled 'Nutrition and Physical Activity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program. Topics include personal history documentation; laboratory procedures; components of energy expenditure; non-exercise activity thermogenesis (NEAT); accurately assessing and understanding body composition; body fat cut-off levels and the inclusion of a "pre-obesity" category. In our article review podcasts, we have carefully...2022-12-1525 minLipid InsightsLipid InsightsS3E2: Statin Underuse PersistenceAlan Brown, MD, FNLA talks with Mary Katherine Cheeley, PharmD, FNLA about the persistence of statin underuse i practice.2022-12-0538 minObesity: A DiseaseObesity: A DiseaseEpisode 71: Article Reviews: Clinical Practice Statements for the Management of Obesity – Cancer and Obesity; Part 2 of 2OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Ethan Lazarus, MD, FOMA, AMA Delegate about the Obesity Medicine Association (OMA) Clinical Practice Statement for which he was first author, titled 'Cancer and Obesity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program. Today's topics include the management and care of patients with obesity following a cancer diagnosis; the need for aggressive treatment of obesity using behavioral, medical and surgical strategies; the benefits of weight loss in cancer patients with obesity; and the devastating...2022-09-0918 minObesity: A DiseaseObesity: A DiseaseEpisode 71: Article Reviews: Clinical Practice Statements for the Management of Obesity - Cancer and Obesity; Part 2 of 2OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Ethan Lazarus, MD, FOMA, AMA Delegate about the Obesity Medicine Association (OMA) Clinical Practice Statement for which he was first author, titled 'Cancer and Obesity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program. Today's topics include the management and care of patients with obesity following a cancer diagnosis; the need for aggressive treatment of obesity using behavioral, medical and surgical strategies; the benefits of weight loss in cancer patients with obesity; and the devastating...2022-09-0918 minObesity: A DiseaseObesity: A DiseaseEpisode 70: Article Reviews: Clinical Practice Statements for the Management of Obesity - Cancer and Obesity; Part 1 of 2OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Ethan Lazarus, MD, FOMA, AMA Delegate about the Obesity Medicine Association (OMA) Clinical Practice Statement for which he was first author, titled 'Cancer and Obesity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program. Today's topics include the complex relationship between cancer and obesity; how the steep decline of nicotine use over the past 30 years can inform us regarding possibilities for obesity management and care; and the nature of fat as a metabolically, hormonally active...2022-09-0920 minObesity: A DiseaseObesity: A DiseaseEpisode 70: Article Reviews: Clinical Practice Statements for the Management of Obesity – Cancer and Obesity; Part 1 of 2OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Ethan Lazarus, MD, FOMA, AMA Delegate about the Obesity Medicine Association (OMA) Clinical Practice Statement for which he was first author, titled 'Cancer and Obesity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program. Today's topics include the complex relationship between cancer and obesity; how the steep decline of nicotine use over the past 30 years can inform us regarding possibilities for obesity management and care; and the nature of fat as a metabolically, hormonally active...2022-09-0920 minObesity: A DiseaseObesity: A DiseaseEpisode 69: Article Reviews: Clinical Practice Statements for the Management of Obesity - Cancer and Obesity; Full PodcastOMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Ethan Lazarus, MD, FOMA, AMA Delegate about the Obesity Medicine Association (OMA) Clinical Practice Statement for which he was first author, titled 'Cancer and Obesity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program. Today's topics include the complex relationship between cancer and obesity; how the steep decline of nicotine use over the past 30 years can inform us regarding possibilities for obesity management and care; and the nature of fat as a metabolically, hormonally active...2022-09-0832 minObesity: A DiseaseObesity: A DiseaseEpisode 69: Article Reviews: Clinical Practice Statements for the Management of Obesity – Cancer and Obesity; Full PodcastOMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Ethan Lazarus, MD, FOMA, AMA Delegate about the Obesity Medicine Association (OMA) Clinical Practice Statement for which he was first author, titled 'Cancer and Obesity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program. Today's topics include the complex relationship between cancer and obesity; how the steep decline of nicotine use over the past 30 years can inform us regarding possibilities for obesity management and care; and the nature of fat as a metabolically, hormonally active...2022-09-0832 minMedication TalkMedication TalkStatin IntoleranceTRC Editor, Dr. Lori Dickerson, PharmD, FCCP talks with Joseph Saseen, PharmD, FCCP, FNLA, Associate Dean for Clinical Affairs, Professor, Department of Clinical Pharmacy and Professor, Department of Family Medicine from the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus about managing statin intolerance. Listen in as they discuss how to evaluate statin-associated muscle pain...and review strategies to help patients take a statin successfully. You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:Andrea Darby Stewart, MD, Associ...2022-09-0132 minObesity: A DiseaseObesity: A DiseaseEpisode 60: Article Reviews: Obesity Definition, Diagnosis, Bias, Standard Operating Procedures (SOPs), and Telehealth; Part 3 of 3: TelehealthThis episode is a segment focusing on obesity Telehealth services from OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interview with Angela K. Fitch MD, FACP, FOMA on the article: Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 on which Dr. Fitch was first author. In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Pillars, which is the official Gold Open Access online-only journal of the Obesity Medicine Association and is devoted...2022-04-0626 minObesity: A DiseaseObesity: A DiseaseEpisode 59: Article Reviews: Obesity Definition, Diagnosis, Bias, Standard Operating Procedures (SOPs), and Telehealth; Part 2 of 3:SOPsThis episode is a segment focusing on SOPs from OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interview with Angela K. Fitch MD, FACP, FOMA on the article: Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 on which Dr. Fitch was first author. In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Pillars, which is the official Gold Open Access online-only journal of the Obesity Medicine Association and is devoted to the publication of...2022-04-0606 minObesity: A DiseaseObesity: A DiseaseEpisode 58: Article Reviews: Obesity Definition, Diagnosis, Bias, Standard Operating Procedures (SOPs), and Telehealth; Part 1 of 3: BiasThis episode is a segment focusing on weight bias Bias from OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interview with Angela K. Fitch MD, FACP, FOMA on the article: Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 on which Dr. Fitch was first author. In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Pillars, which is the official Gold Open Access online-only journal of the Obesity Medicine Association and is devoted...2022-04-0609 minObesity: A DiseaseObesity: A DiseaseEpisode 57: Article Reviews: Obesity Definition, Diagnosis, Bias, Standard Operating Procedures (SOPs), and Telehealth; Full PodcastIn this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Angela K. Fitch MD, FACP, FOMA on the article: Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 on which Dr. Fitch was first author. In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Pillars, which is the official Gold Open Access online-only journal of the Obesity Medicine Association and is devoted to the publication of clinical and evidence-based research for...2022-04-0535 minSouth African Border WarsSouth African Border WarsEpisode 48 – Russian specialists set up anti-aircraft missiles and Special Forces ops accelerate across the cutlineThe Russians were increasing their support for the MPLA in Luanda and one of those who arrived was Vladimir Vasilievich Kostrachenkov. He helped establish the Pechora Anti-Aircraft system between 1979 and 1981 in the south of Angola and published some of his thoughts in a book called Bush War, the Road to Cuito Cuanavale. While most of this book is about the major battles that took place later around Cuito, Kostrachenkov’s explanation of what happened in the south in the very 80s is important for us at this juncture. It was his second tour of duty of Angola – his first was...2022-02-2723 minObesity: A DiseaseObesity: A DiseaseEpisode 46: Article Reviews: Determinants of Weight Loss Maintenance In this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC and Sarah Wells, MD discuss a recent article about the determinants of weight loss maintenance. Topics covered include what determinants were found to be positively predictive in weight loss maintenance, which determinants are non-significant for weight loss maintenance, and how to translate this article into clinical application. In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Medicine Association (OMA) Obesity Algorithm, which is a comprehensive review of obesity medicine that...2021-09-0313 minObesity: A DiseaseObesity: A DiseaseEpisode 44: Article Reviews: Patient Assisted Virtual PhysicalIn this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Carolynn Francavilla, MD, FOMA to discuss a recent article on virtual physicals using telehealth. Topics covered include: Individualizing the telehealth physical exam, limitations and opportunities of the telehealth exam, and challenges for prescribing anti-obesity medications by telehealth. To access other resources from the clinical leader in Obesity Medicine, visit www.obesitymedicine.org. Episode Guests Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC Carolynn Francavilla, MD, FOMA Resources Mentioned The Telehealth Ten...2021-08-0414 minObesity: A DiseaseObesity: A DiseaseEpisode 42: Article Reviews: Safety and Effectiveness of Longer-Term Phentermine Use In this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Mahtab Ahmed, MD, FOMA, Dipl. ABOM about a recent article on the safety and effectiveness of longer-term Phentermine use. Topics covered include risks and benefits of prescribing Phentermine longer than 12 weeks, the impact of study results only including low cardiovascular disease risk patients and being a retrospective study, and the role of local regulations in prescribing. In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Medicine Association (OMA) Obesity Algorithm, which...2021-06-3017 minSouth African Border WarsSouth African Border WarsEpisode 18 – The Battle of Ebo - the first major defeat for the SADF during Operation SavannahThis is episode 18 and folks back home were in for a bit of a shock. The invasion of Angola by the SADF during Operation Savannah had been an exercise in support of both Unita and the FNLA – but the government had said that the South Africans were merely technical support. The reality was hundreds of SADF troops were directly involved in the fighting – and had fought all the way to south of the capital Luanda. This was almost a thousand kilometers inside Angola. As we heard last episode, by the end of November a group of liaison officers and...2021-06-2819 minSouth African Border WarsSouth African Border WarsEpisode 17 – The SAS Steyn’s role in the remarkable evacuation from the beach at AmbrizetteThis is episode 17 and we’re approaching the end of Operation Savannah which had started out so well but was rapidly turning into a strategic nightmare for the South Africans. One of the fastest mechanised invasions since World War Two had resulted in the SADF now deep into Angola – and in the case of Brigadier Roos who was a liaison officer based in Ambriz with the FNLA – he was cut off on the coast to the north of the capital Luanda. IT was mid-November 1975 and the MPLA and Cubans were starting to move determined to rid the co...2021-06-2119 minSouth African Border WarsSouth African Border WarsEpisode 16 – Luanda’s “Death Road” leaves the FNLA in tatters and the CIA decides to up and offThis is episode 16 and we’re covering Operation Savannah which took place between October and December 1975. That was the invasion of southern Angola by the South African Defence Force in response to the outbreak of a civil war in the country involving the three main independence movements that had fought against Portuguese colonial rule. These were the MPLA, Unita and the FNLA. Our focus in this episode shifts in a while to the FNLA’s assault on the Capital Luanda. But first an update about the SADF. Brigadier Schoeman who was in char...2021-06-1418 minObesity: A DiseaseObesity: A DiseaseEpisode 40: Article Reviews: Long-Term Weight Loss in the Diabetes Prevention Program In this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Laura Davisson, MD, MPH, FACP, to discuss a recent article on the comparison of Metformin and lifestyle intervention in diabetes prevention. Topics covered include the success of the intensive lifestyle intervention of the Diabetes Prevention Program, the difficulty many patients have with weight loss maintenance, and the consideration of prescribing Metformin for prediabetes. In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Medicine Association (OMA) Obesity Algorithm, which is a comprehensive...2021-06-0712 minObesity: A DiseaseObesity: A DiseaseEpisode 38: Article Reviews: Stress and Obesity In this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Angela Golden, DNP, FNP-C, FAANP, to discuss a recent article on the connection between stress and obesity. Topics covered include clinical strategies for talking to patients about stress and obesity, the role of obesity bias and stigma in increasing patient stress, and how to manage hormones related to stress. Episode Guests Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC Angela Golden, DNP, FNP-C, FAANP Resources Mentioned Tomiyama AJ: Stress and Obesity. Annu Rev...2021-05-0313 minObesity: A DiseaseObesity: A DiseaseEpisode 37: Clinical Conversations: Anti-Obesity Medicines Under Development In this episode, obesity medicine specialist and OMA Clinical Education Director, Nicholas Pennings, DO, FOMA, Dipl. ABOM interviews Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC, a highlighted speaker from Overcoming Obesity 2020 – Virtual, about new pharmaceutical agents in development to treat obesity. Topics covered include why anti-obesity medicines may be necessary in treatment, treatment targets and efficacy of newer pharmaceutical agents, role of combination medications in treatment, and a discussion about stigma and bias around anti-obesity medications. You can access more information about Obesity Medicine podcasts and other resources from the clinical leader in Obesity Medicine at ww...2021-04-1935 minObesity: A DiseaseObesity: A DiseaseEpisode 36: Clinical Conversations: Starting an Obesity Medicine Practice In this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Karli Burridge, PA-C, MMS, FOMA to discuss her experience in starting an obesity medicine practice. Topics covered include: practice components and structure to consider when starting a practice, general business start-up practices, payment, and practice models, and recommended standard operating procedures. To access other resources from the clinical leader in Obesity Medicine, visit: www.obesitymedicine.org. Episode Guests Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC Karli Burridge, PA-C, MMS, FOMA Resources Mentioned2021-04-0533 minTaxi BrousseTaxi BrousseEpisode 20Angelique – Lokassa Ya Mbongo (Congo)Petit précis sur les Congo.La république démocratique du Congo, parfois appelée Congo-Kinshasa du nom de sa capitale, anciennement État indépendant du Congo (1877-1908), Congo belge (1908-1960), république du Congo-Léopoldville (1960-1964), république démocratique du Congo (1964-1971) et Zaïre de 1971 à 1997, 97 c’est la fin du règne de Joseph-Désiré Mobutu.Son voisin, le Congo, parfois appelé Congo-Brazaville, était une colonie française. Qui porta aussi le nom de République congolaise de 1960 à 1965, république du Congo de 1965 à 1969 et de république populaire du Congo de 1969...2019-11-2400 minObesity: A DiseaseObesity: A DiseaseEpisode 3: Article Reviews: Progress and Challenges in Anti-Obesity PharmacotherapyEpisode Description In our article review podcasts, we have carefully selected recent articles included in the latest version of the OMA Obesity Algorithm.  We then discuss this new science with obesity experts. In this episode, Harold Bays, MD, FOMA, FTOS, FACC, FACE, FNLA, Dipl. ABOM interviews Larry Richardson, MD, MFOMA about a recent publication on progress and challenges in anti-obesity pharmacotherapy. Topics covered include: barriers to the use of anti-obesity medication, new, most promising agents being considered that may come to fruition, and dialoging about the resistance of combination therapy for treating obesity. To access other resources from the clinical l...2019-08-0510 miniUniverseiUniverseBrian Scott Edwards, MD, FNLA, S. T. Byra and Leo CauzilloiUniverse Radio order of interviews for show: 3:00-4:00PM EST 1. “The Chronic Disease of Obesity: How Sponge Syndrome Causes Repeated Weight Gain”; by Brian Scott Edwards, MD, FNLA 2. “One and One Is One: The Beginning”; by S. T. Byra 3. “They are Not Alone: Mythology or History”; by Leo Cauzillo2019-06-1047 minThe Peter Attia DriveThe Peter Attia DriveTom Dayspring, M.D., FACP, FNLA – Part V of V: Lp(a), inflammation, oxLDL, remnants, and moreIn this five-part series, Thomas Dayspring, M.D., FACP, FNLA, a world-renowned expert in lipidology, and one of Peter's most important clinical mentors, shares his wealth of knowledge on the subject of lipids. In Part V, Peter and Tom talk about inflammation, endothelial health, and oxidative stress as they pertain to cardiovascular disease, and our attempts to monitor them using biomarkers. They also discuss a couple of very important risk factors that too few people (and doctors) know about. Tom closes the five-part series with a tragic story about his good friend that is likely all-too-common for many practicing...2018-10-191h 29The Peter Attia DriveThe Peter Attia DriveTom Dayspring, M.D., FACP, FNLA – Part IV of V: Statins, ezetimibe, PCSK9 inhibitors, niacin, cholesterol and the brainIn this five-part series, Thomas Dayspring, M.D., FACP, FNLA, a world-renowned expert in lipidology, and one of Peter's most important clinical mentors, shares his wealth of knowledge on the subject of lipids. In Part IV, Peter and Tom review the history and current use of drugs to prevent cardiovascular disease. They also discuss why some drugs appear to be more effective than others, an in-depth conversation about niacin, cholesterol and brain health, and the futility of using CKs (creatinine kinase) and liver function tests to identify adverse effects in statins, to name a few topics in this episode.2018-10-182h 00The Peter Attia DriveThe Peter Attia DriveTom Dayspring, M.D., FACP, FNLA – Part III of V: HDL, reverse cholesterol transport, CETP inhibitors, and apolipoproteinsIn this five-part series, Thomas Dayspring, M.D., FACP, FNLA, a world-renowned expert in lipidology, and one of Peter's most important clinical mentors, shares his wealth of knowledge on the subject of lipids. In Part III, Peter and Tom dig into HDL, why "reverse cholesterol transport" is a lot more nuanced than what most of us are taught, lipid transport, apolipoproteins, and more. In addition, this episode highlights the complexity of HDL and a discussion about the CETP inhibitor trials. We discuss: Reverse cholesterol transport [1:40]; Lipid transportation, apolipoproteins, VLDL, IDL, and LDL particles [11:00]; Remnant lipoproteins and...2018-10-171h 04The Peter Attia DriveThe Peter Attia DriveTom Dayspring, M.D., FACP, FNLA – Part II of V: Lipid metrics, lipid measurements, and cholesterol regulation In this five-part series, Thomas Dayspring, M.D., FACP, FNLA, a world-renowned expert in lipidology, and one of Peter's most important clinical mentors, shares his wealth of knowledge on the subject of lipids. In Part II, Tom provides a 101 on lipids and lipoproteins. Tom and Peter also discuss the history and techniques used to measure lipoproteins, and more.   We discuss:  Lipoprotein basics [1:30]; Gofman and the ultracentrifuge [5:15]; Lipoprotein structure, function, metabolism [6:45]; Lipoprotein and cholesterol measurement, and NMR technology [15:15]; LDL-C vs LDL-P and apoB [30:45]; Sterols and cholesterol synthesis [39:45]; and More. Learn more at www.PeterAttiaMD.com Connect with Peter on...2018-10-161h 26The Peter Attia DriveThe Peter Attia DriveThomas Dayspring, M.D., FACP, FNLA – Part I of V: an introduction to lipidologyIn this five-part series, Thomas Dayspring, M.D., FACP, FNLA, a world-renowned expert in lipidology, and one of Peter's most important clinical mentors, shares his wealth of knowledge on the subject of lipids. Part I serves as an introduction to Tom, his work, and an overview of lipid terminology. We discuss: Tom’s recent and remarkable physical transformation [6:30]; The moving stories behind Tom’s obsessions: firefighting, hockey, and, of course, lipids [20:30]; Tom’s medical background [39:30]; Producing some of the most accessible diagrams on lipids [50:00]; What are the different kinds of lipids, what do they do, and how ar...2018-10-151h 14Lipid LuminationsLipid LuminationsCardiovascular Risk Reduction in the Elderly: Best Lipid Strategies Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA Host Dr. Alan Brown welcomes Joyce Ross, MSN, CRNP, FNLA, President-Elect of the National Lipid Association. Joyce serves as a consultative education specialist in cardiovascular risk intervention with the University of Pennsylvania Health System. Their discussion focuses on lipid management to reduce atherosclerotic cardiovascular disease (ASCVD) risk in elderly patient populations. Thhis interview was recorded live at the National Lipid Association in San Diego, California for the 2016 Spring Clinical Lipid Update.2016-05-0900 minVascular MedicineVascular MedicineCardiovascular Risk Reduction in the Elderly: Best Lipid Strategies Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA Host Dr. Alan Brown welcomes Joyce Ross, MSN, CRNP, FNLA, President-Elect of the National Lipid Association. Joyce serves as a consultative education specialist in cardiovascular risk intervention with the University of Pennsylvania Health System. Their discussion focuses on lipid management to reduce atherosclerotic cardiovascular disease (ASCVD) risk in elderly patient populations. Thhis interview was recorded live at the National Lipid Association in San Diego, California for the 2016 Spring Clinical Lipid Update.2016-05-0900 minGeriatricsGeriatricsCardiovascular Risk Reduction in the Elderly: Best Lipid Strategies Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA Host Dr. Alan Brown welcomes Joyce Ross, MSN, CRNP, FNLA, President-Elect of the National Lipid Association. Joyce serves as a consultative education specialist in cardiovascular risk intervention with the University of Pennsylvania Health System. Their discussion focuses on lipid management to reduce atherosclerotic cardiovascular disease (ASCVD) risk in elderly patient populations. Thhis interview was recorded live at the National Lipid Association in San Diego, California for the 2016 Spring Clinical Lipid Update.2016-05-0900 minFocus on Heart HealthFocus on Heart HealthCardiovascular Risk Reduction in the Elderly: Best Lipid StrategiesHost: Alan S. Brown, MD, FNLA Guest: Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA Host Dr. Alan Brown welcomes Joyce Ross, MSN, CRNP, FNLA, President-Elect of the National Lipid Association. Joyce serves as a consultative education specialist in cardiovascular risk intervention with the University of Pennsylvania Health System. Their discussion focuses on lipid management to reduce atherosclerotic cardiovascular disease (ASCVD) risk in elderly patient populations. Thhis interview was recorded live at the National Lipid Association in San Diego, California for the 2016 Spring Clinical Lipid Update.2016-05-0900 minCardiologyCardiologyCardiovascular Risk Reduction in the Elderly: Best Lipid Strategies Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA Host Dr. Alan Brown welcomes Joyce Ross, MSN, CRNP, FNLA, President-Elect of the National Lipid Association. Joyce serves as a consultative education specialist in cardiovascular risk intervention with the University of Pennsylvania Health System. Their discussion focuses on lipid management to reduce atherosclerotic cardiovascular disease (ASCVD) risk in elderly patient populations. Thhis interview was recorded live at the National Lipid Association in San Diego, California for the 2016 Spring Clinical Lipid Update.2016-05-0900 minGeriatricsGeriatricsCardiovascular Risk Reduction in the Elderly: Best Lipid Strategies Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA Host Dr. Alan Brown welcomes Joyce Ross, MSN, CRNP, FNLA, President-Elect of the National Lipid Association. Joyce serves as a consultative education specialist in cardiovascular risk intervention with the University of Pennsylvania Health System. Their discussion focuses on lipid management to reduce atherosclerotic cardiovascular disease (ASCVD) risk in elderly patient populations. Thhis interview was recorded live at the National Lipid Association in San Diego, California for the 2016 Spring Clinical Lipid Update.2016-05-0900 minCardiologyCardiologyCardiovascular Risk Reduction in the Elderly: Best Lipid Strategies Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA Host Dr. Alan Brown welcomes Joyce Ross, MSN, CRNP, FNLA, President-Elect of the National Lipid Association. Joyce serves as a consultative education specialist in cardiovascular risk intervention with the University of Pennsylvania Health System. Their discussion focuses on lipid management to reduce atherosclerotic cardiovascular disease (ASCVD) risk in elderly patient populations. Thhis interview was recorded live at the National Lipid Association in San Diego, California for the 2016 Spring Clinical Lipid Update.2016-05-0900 minLipid LuminationsLipid LuminationsThe Lipidology Essentials: Making of a Specialty's Annual Summary Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Harold Bays, MD, FNLA Dr. Alan Brown welcomes Dr. Harold Bays, President of the Southeast Lipid Association and President of the Louisville Metabolic and Atherosclerotic Research Center in Louisville, KY. Dr. Bays led a novel educational effort to provide an annual summary of clinical lipidology to readers of the Journal of Clinical Lipidology. With insightful commentaries of value to lipidologists and generalists alike, the annual summary is expected to pave new ground in the ongoing effort to keep clinicians up to date with the field. 2016-04-1800 minVascular MedicineVascular MedicineUpdated NLA Recommendations for African American Patients Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA Host Dr. Alan Brown is joined by Dr. Keith C. Ferdinand, Professor at Tulane University School of Medicine in New Orleans, Louisiana. Dr. Ferdinand reviews the etiologies, diagnostic challenges, and management considerations for selective cardiac health issues prevalent in African American populations, from hypertension to coronary arterial calcium plaques to lipid levels. Supported by an Educational Grant from AstraZeneca. 2015-08-0300 minLipid LuminationsLipid LuminationsUpdated NLA Recommendations for African American Patients Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA Host Dr. Alan Brown is joined by Dr. Keith C. Ferdinand, Professor at Tulane University School of Medicine in New Orleans, Louisiana. Dr. Ferdinand reviews the etiologies, diagnostic challenges, and management considerations for selective cardiac health issues prevalent in African American populations, from hypertension to coronary arterial calcium plaques to lipid levels. Supported by an Educational Grant from AstraZeneca. 2015-08-0300 minLipid LuminationsLipid LuminationsDyslipidemia in The Elderly: How Old is "Too Old" to Treat? Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA One of the most recurrent questions that cardiologists and lipidologists face in daily practice is how to best approach the elderly patient with dyslipidemia. Joining Dr. Alan Brown for special considerations in this population and guideline-based recommendations for management is Joyce Ross, certified registered nurse practitioner, clinical lipid specialist, and President-Elect of the National Lipid Association. Supported by an Educational Grant from AstraZeneca. 2015-07-2700 minCongo LiveCongo LiveJames L Hope: Black Lives Matter - from Baltimore to the CongoJames L. Hope joins Congo Live! to discuss his time in the Congo and the current situation in Baltimore. He was also in the Congo in the 1960s and kept the tradition alive of supporting liberation movement on the African continent. We will also discuss current affairs in Baltimore. Bio: James L. Hope is the International Advisor of the African Scientific Institute (ASI). He first set foot on the African Continent in 1951 when his ship stopped in Alexandria, Egypt on its way to Beirut, Lebanon where he took up residence and attended school. Over the years Mr. Hope assisted in...2015-05-0400 minVideo LibraryVideo LibraryRoles of Non-HDL Cholesterol in Risk Assessment and TreatmentHost: Alan S. Brown, MD, FNLA A paradigm shift in the management of lipid disorders has been witnessed of late based on evidence reviews by the AHA and the ACC. Where the clinical dogma once focused on targeting specific lipoproteins, clinicians are now trending toward using appropriate dosages of statins for lowering non-HDL cholesterol. What are the ramifications of this change in approach, and how does the NLA weigh in on recommendations for targets and goals? To address these and other questions, host Dr. Alan Brown welcomes Kevin Maki, PhD, FNLA, CLS, Chief Science Officer for Midwest Center...2014-09-1600 minMedical ResearchMedical ResearchRoles of Non-HDL Cholesterol in Risk Assessment and Treatment Host: Alan S. Brown, MD, FACC, FAHA, FNLA A paradigm shift in the management of lipid disorders has been witnessed of late based on evidence reviews by the AHA and the ACC. Where the clinical dogma once focused on targeting specific lipoproteins, clinicians are now trending toward using appropriate dosages of statins for lowering non-HDL cholesterol. What are the ramifications of this change in approach, and how does the NLA weigh in on recommendations for targets and goals? To address these and other questions, host Dr. Alan Brown welcomes Kevin Maki, PhD, FNLA, CLS, Chief Science Officer for...2014-09-1600 minLipid LuminationsLipid LuminationsRoles of Non-HDL Cholesterol in Risk Assessment and Treatment Host: Alan S. Brown, MD, FACC, FAHA, FNLA A paradigm shift in the management of lipid disorders has been witnessed of late based on evidence reviews by the AHA and the ACC. Where the clinical dogma once focused on targeting specific lipoproteins, clinicians are now trending toward using appropriate dosages of statins for lowering non-HDL cholesterol. What are the ramifications of this change in approach, and how does the NLA weigh in on recommendations for targets and goals? To address these and other questions, host Dr. Alan Brown welcomes Kevin Maki, PhD, FNLA, CLS, Chief Science Officer for...2014-09-1600 minMedical ResearchMedical ResearchKeys to the Latest NLA Recommendations for Dyslipidemia Treatments Host: Alan S. Brown, MD, FACC, FAHA, FNLA What's the evidence for LDL and other non-HDL targets for primary and secondary prevention of heart disease? What are the comparative benefits versus toxicities of all lipid-lowering medications in clinical use? Addressing these and other questions from the standpoing of recent NLA recommendations is Kevin Maki, PhD, FNLA, CLS, Chief Science Officer for Midwest Center for Metabolic and Cardiovascular Research and Adjunct Faculty in Biostatistics and Applied Epidemiology at DePaul University, Chicago, IL. Produced in partnership with 2014-09-0900 minVideo LibraryVideo LibraryKeys to the Latest NLA Recommendations for Dyslipidemia TreatmentsHost: Alan S. Brown, MD, FNLA What's the evidence for LDL and other non-HDL targets for primary and secondary prevention of heart disease? What are the comparative benefits versus toxicities of all lipid-lowering medications in clinical use? Addressing these and other questions from the standpoing of recent NLA recommendations is Kevin Maki, PhD, FNLA, CLS, Chief Science Officer for Midwest Center for Metabolic and Cardiovascular Research and Adjunct Faculty in Biostatistics and Applied Epidemiology at DePaul University, Chicago, IL. Produced in partnership with 2014-09-0900 minLipid LuminationsLipid LuminationsKeys to the Latest NLA Recommendations for Dyslipidemia Treatments Host: Alan S. Brown, MD, FACC, FAHA, FNLA What's the evidence for LDL and other non-HDL targets for primary and secondary prevention of heart disease? What are the comparative benefits versus toxicities of all lipid-lowering medications in clinical use? Addressing these and other questions from the standpoing of recent NLA recommendations is Kevin Maki, PhD, FNLA, CLS, Chief Science Officer for Midwest Center for Metabolic and Cardiovascular Research and Adjunct Faculty in Biostatistics and Applied Epidemiology at DePaul University, Chicago, IL. Produced in partnership with 2014-09-0900 minLipid LuminationsLipid LuminationsManagement of the Patient With Triglycerides 200-499 mg/dl. Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Carl Orringer, MD, FACC, FNLA What are some of the causes of high triglycerides? What is the biggest health risk? And, for these patients, at what level is the risk greater for developing pancreatitis and coronary artery disease? Host Dr. Alan Brown welcomes Dr. Carl Orringer, Associate Professor of Medicine at the Cardiology Division, University of Miami Medical Center and Director of the Preventive Cardiovascular Medicine and LDL apheresis program. In this edition of Lipid Luminations, Dr. Orringer will discuss the management of the patients with triglycerides 200-499...2014-08-2600 minVideo LibraryVideo LibraryManagement of the Patient With Triglycerides 200-499 mg/dl.Host: Alan S. Brown, MD, FNLA Guest: Carl Orringer, MD, FACC, FNLA What are some of the causes of high triglycerides? What is the biggest health risk? And, for these patients, at what level is the risk greater for developing pancreatitis and coronary artery disease? Host Dr. Alan Brown welcomes Dr. Carl Orringer, Associate Professor of Medicine at the Cardiology Division, University of Miami Medical Center and Director of the Preventive Cardiovascular Medicine and LDL apheresis program. In this edition of Lipid Luminations, Dr. Orringer will discuss the management of the patients with triglycerides 200-499 mg/dl.2014-08-2600 minLipid LuminationsLipid LuminationsWhat is the Safety of Statins in Patients with Diabetes? Guest: Kevin C. Maki, PhD, FNLA, CLS Host: Alan S. Brown, MD, FACC, FAHA, FNLA At the most recent National Lipid Association (NLA) meeting, host Dr. Alan Brown welcomes Kevin Maki, PhD, FNLA, CLS, Chief Science Officer for Midwest Center for Metabolic and Cardiovascular Research and Adjunct Faculty position in Biostatistics and Applied Epidemiology at DePaul University, Chicago, IL. Drs. Brown and Maki discuss the evidence of the relationship of statin use and risk of new onset of diabetes; as well as, the relationship of statin use and the possiblity of worsening glycemia in those patients who...2014-05-1300 minCardiologyCardiologyWhat is the Safety of Statins in Patients with Diabetes? Guest: Kevin C. Maki, PhD, FNLA, CLS Host: Alan S. Brown, MD, FACC, FAHA, FNLA At the most recent National Lipid Association (NLA) meeting, host Dr. Alan Brown welcomes Kevin Maki, PhD, FNLA, CLS, Chief Science Officer for Midwest Center for Metabolic and Cardiovascular Research and Adjunct Faculty position in Biostatistics and Applied Epidemiology at DePaul University, Chicago, IL. Drs. Brown and Maki discuss the evidence of the relationship of statin use and risk of new onset of diabetes; as well as, the relationship of statin use and the possiblity of worsening glycemia in those patients who...2014-05-1300 minCardiologyCardiologyWhat is the Safety of Statins in Patients with Diabetes? Guest: Kevin C. Maki, PhD, FNLA, CLS Host: Alan S. Brown, MD, FACC, FAHA, FNLA At the most recent National Lipid Association (NLA) meeting, host Dr. Alan Brown welcomes Kevin Maki, PhD, FNLA, CLS, Chief Science Officer for Midwest Center for Metabolic and Cardiovascular Research and Adjunct Faculty position in Biostatistics and Applied Epidemiology at DePaul University, Chicago, IL. Drs. Brown and Maki discuss the evidence of the relationship of statin use and risk of new onset of diabetes; as well as, the relationship of statin use and the possiblity of worsening glycemia in those patients who...2014-05-1300 minMiscellaneous TopicsMiscellaneous TopicsWhat is the Safety of Statins in Patients with Diabetes?Guest: Kevin C. Maki, PhD, FNLA, CLS Host: Alan S. Brown, MD, FNLA At the most recent National Lipid Association (NLA) meeting, host Dr. Alan Brown welcomes Kevin Maki, PhD, FNLA, CLS, Chief Science Officer for Midwest Center for Metabolic and Cardiovascular Research and Adjunct Faculty position in Biostatistics and Applied Epidemiology at DePaul University, Chicago, IL. Drs. Brown and Maki discuss the evidence of the relationship of statin use and risk of new onset of diabetes; as well as, the relationship of statin use and the possiblity of worsening glycemia in those patients who have diabetes...2014-05-1300 minLipid LuminationsLipid LuminationsNational Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia Guest: Carl Orringer, MD, FACC, FNLA Guest: Kevin C. Maki, PhD, FNLA, CLS Guest: Harold Bays, MD, FNLA Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Matthew Ito, PharmD, FNLA Host Dr. Alan Brown is joined by an expert panel to discuss the NLA's latest draft document that will serve as recommendations to clinicians for the management of patients with dyslipidemia. The National Lipid Association's goal was to harmonize guidelines among what has been presented in the past by the ATP panel, the American College of Cardiology/American Heart Association Guidelines, and those...2014-05-0800 minCardiologyCardiologyNational Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia Guest: Carl Orringer, MD, FACC, FNLA Guest: Kevin C. Maki, PhD, FNLA, CLS Guest: Harold Bays, MD, FNLA Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Matthew Ito, PharmD, FNLA Host Dr. Alan Brown is joined by an expert panel to discuss the NLA's latest draft document that will serve as recommendations to clinicians for the management of patients with dyslipidemia. The National Lipid Association's goal was to harmonize guidelines among what has been presented in the past by the ATP panel, the American College of Cardiology/American Heart Association Guidelines, and those...2014-05-0800 minMiscellaneous TopicsMiscellaneous TopicsNational Lipid Association Recommendations for Patient-Centered Management of DyslipidemiaGuest: Kevin C. Maki, PhD, FNLA, CLS Guest: Carl Orringer, MD, FACC, FNLA Guest: Harold Bays, MD, FNLA Host: Alan S. Brown, MD, FNLA Guest: Matthew Ito, PharmD, FNLA Host Dr. Alan Brown is joined by an expert panel to discuss the NLA's latest draft document that will serve as recommendations to clinicians for the management of patients with dyslipidemia. The National Lipid Association's goal was to harmonize guidelines among what has been presented in the past by the ATP panel, the American College of Cardiology/American Heart Association Guidelines, and those also released...2014-05-0800 minCardiologyCardiologyNational Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia Guest: Carl Orringer, MD, FACC, FNLA Guest: Kevin C. Maki, PhD, FNLA, CLS Guest: Harold Bays, MD, FNLA Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Matthew Ito, PharmD, FNLA Host Dr. Alan Brown is joined by an expert panel to discuss the NLA's latest draft document that will serve as recommendations to clinicians for the management of patients with dyslipidemia. The National Lipid Association's goal was to harmonize guidelines among what has been presented in the past by the ATP panel, the American College of Cardiology/American Heart Association Guidelines, and those...2014-05-0800 minLipid LuminationsLipid LuminationsObesity, Diabetes and the Metabolic Syndrome Guest: Kevin C. Maki, PhD, FNLA, CLS Host: Alan S. Brown, MD, FACC, FAHA, FNLA Host Dr. Alan S. Brown is joined by Kevin C. Maki, PhD, FNLA, Chief Science Officer of Biofortis Clinical Research. Dr. Maki will review obesity, metabolic syndrome and type 2 diabetes mellitus as they are all insulin resistant states and are often characterized by atherogenic dyslipidemia or the "lipid triad" of elevated triglycerides, low HDL cholesterol and a predominance of small, dense LDL particles.2013-02-2500 minMiscellaneous TopicsMiscellaneous TopicsObesity, Diabetes and the Metabolic SyndromeGuest: Kevin C. Maki, PhD, FNLA, CLS Host: Alan S. Brown, MD, FNLA Host Dr. Alan S. Brown is joined by Kevin C. Maki, PhD, FNLA, Chief Science Officer of Biofortis Clinical Research. Dr. Maki will review obesity, metabolic syndrome and type 2 diabetes mellitus as they are all insulin resistant states and are often characterized by atherogenic dyslipidemia or the "lipid triad" of elevated triglycerides, low HDL cholesterol and a predominance of small, dense LDL particles.2013-02-2500 minEndocrinologyEndocrinologyEvolving Treatments: A Review of What’s in the Pipeline Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Harold Bays, MD, FNLA Host Dr. Alan Brown and guest, Dr. Harold Bays discuss the evolving treatments in lipid management and what we will be expecting in the future. They will address the role of niacin, the status of laropiprant, an overview of fish oils and omega-3 fatty acids and the novel approaches being used in today's research of lipid-altering drugs. Harold E. Bays MD, FACP, FACE, FNLA is the Medical Director and President of the Louisville Metabolic and Atherosclerosis Research Center Inc. (L-MARC) in Louisville...2012-09-2100 minMiscellaneous TopicsMiscellaneous TopicsEvolving Treatments: A Review of What’s in the PipelineGuest: Harold Bays, MD, FNLA Host: Alan S. Brown, MD, FNLA Host Dr. Alan Brown and guest, Dr. Harold Bays discuss the evolving treatments in lipid management and what we will be expecting in the future. They will address the role of niacin, the status of laropiprant, an overview of fish oils and omega-3 fatty acids and the novel approaches being used in today's research of lipid-altering drugs. Harold E. Bays MD, FACP, FACE, FNLA is the Medical Director and President of the Louisville Metabolic and Atherosclerosis Research Center Inc. (L-MARC) in ...2012-09-2100 minEndocrinologyEndocrinologyEvolving Treatments: A Review of What’s in the Pipeline Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Harold Bays, MD, FNLA Host Dr. Alan Brown and guest, Dr. Harold Bays discuss the evolving treatments in lipid management and what we will be expecting in the future. They will address the role of niacin, the status of laropiprant, an overview of fish oils and omega-3 fatty acids and the novel approaches being used in today's research of lipid-altering drugs. Harold E. Bays MD, FACP, FACE, FNLA is the Medical Director and President of the Louisville Metabolic and Atherosclerosis Research Center Inc. (L-MARC) in Louisville...2012-09-2100 minLipid LuminationsLipid LuminationsEvolving Treatments: A Review of What’s in the Pipeline Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Harold Bays, MD, FNLA Host Dr. Alan Brown and guest, Dr. Harold Bays discuss the evolving treatments in lipid management and what we will be expecting in the future. They will address the role of niacin, the status of laropiprant, an overview of fish oils and omega-3 fatty acids and the novel approaches being used in today's research of lipid-altering drugs. Harold E. Bays MD, FACP, FACE, FNLA is the Medical Director and President of the Louisville Metabolic and Atherosclerosis Research Center Inc. (L-MARC) in Louisville...2012-09-2100 minMedical ResearchMedical ResearchEmerging HDL Therapies: What’s Next on the Clinical Research Horizon Guest: Benjamin J. Ansell, MD, FACC, FACP, FNLA Host: Alan S. Brown, MD, FACC, FAHA, FNLA Host Dr. Alan Brown welcomes Benjamin Ansell, MD, professor of medicine and cardiology at University of Califronia at Los Angeles, CA and co-director of the Cholesterol and Hypertension Management Program at UCLA. Dr. Ansell reviews the latest trials: dal-OUTCOMES and AIM-HIGH. Dr. Ansell will address the objectives and study designs of both studies and explain why the studies were stopped early. Drs. Brown and Ansell also discuss the future of HDL therapy. Brought to you by:2012-07-0900 minPreventive MedicinePreventive MedicineEmerging HDL Therapies: What’s Next on the Clinical Research Horizon Guest: Benjamin J. Ansell, MD, FACC, FACP, FNLA Host: Alan S. Brown, MD, FACC, FAHA, FNLA Host Dr. Alan Brown welcomes Benjamin Ansell, MD, professor of medicine and cardiology at University of Califronia at Los Angeles, CA and co-director of the Cholesterol and Hypertension Management Program at UCLA. Dr. Ansell reviews the latest trials: dal-OUTCOMES and AIM-HIGH. Dr. Ansell will address the objectives and study designs of both studies and explain why the studies were stopped early. Drs. Brown and Ansell also discuss the future of HDL therapy. Brought to you by:2012-07-0900 minLipid LuminationsLipid LuminationsEmerging HDL Therapies: What’s Next on the Clinical Research Horizon Guest: Benjamin J. Ansell, MD, FACC, FACP, FNLA Host: Alan S. Brown, MD, FACC, FAHA, FNLA Host Dr. Alan Brown welcomes Benjamin Ansell, MD, professor of medicine and cardiology at University of Califronia at Los Angeles, CA and co-director of the Cholesterol and Hypertension Management Program at UCLA. Dr. Ansell reviews the latest trials: dal-OUTCOMES and AIM-HIGH. Dr. Ansell will address the objectives and study designs of both studies and explain why the studies were stopped early. Drs. Brown and Ansell also discuss the future of HDL therapy. Brought to you by:2012-07-0900 min